聚焦渐冻症（ALS）等重大神经退行性疾病，整合并创新多组学、空间组学和深度学习等手段，探索疾病的分子、细胞和空间机制。已发表SCI论文53篇，影响因子累计约310，被引用>2600次（Google scholar），H-index =30。近几年的工作整合甲基化组和基因组学研究，揭示了多种遗传/衰老因素与表型异质性有关 (Brain 2018, Brain 2019, Acta Neuropathol 2020，Movement Disorders 2022，均为通讯)；开发了新的计算生物学工具解析组织空间转录组数据中基因表达的空间易感性，揭示了ALS基因的皮层易感区域和新的ALS风险基因（Brain 2024，通讯）。主持多项国自然面上和上海市科委项目。担任上海市医学遗传学学会委员。受邀担任Nature Communications, Acta Neuropathologica等期刊评审，Alzheimer society of UK、MND Association (UK)项目评审。
Dr. Zhang’s lab focuses on major neurodegenerative diseases (such as ALS). We are interested in innovating novel technologies, such as multi-omics, spatial omics and deep learning to explore novel molecular, cellular and spatial mechanisms underlying brain diseases. Dr. Zhang has published >53 SCI papers, with a cumulative impact factor of approximately 310, cited by >2600 times (Google scholar), and H-index =30. His recent work integrated methylome and genomic studies that revealed multiple genetic and aging factors linked to phenotypic heterogeneity (Brain 2018, Brain 2019, Acta Neuropathol 2020, Movement Disorders 2022, as corresponding authors). He also developed novel computational tools to pinpoint the spatial susceptibility of gene expression derived from spatial transcriptomic data of human and mouse tissues, identifying layer 5 cortical region as an ALS susceptible region and nominated novel ALS risk genes (Brain 2024, as a leading corresponding author). Dr. Zhang lead multiple projects funded by National Natural Science Foundation of China and Shanghai Municipal Science and Technology Commission. He also served as a committee member of the Shanghai Society of Medical Genetics. He was invited to serve as a reviewer for Nature Communications, Acta Neuropathologica and many other academic journals, and an external grant reviewer for Alzheimer society of UK and Motor Neuron Disease Association (UK).
代表性论文：
1. Jingyan Guo, Linya You, Yu Zhou, Jiali Hu, Jiahao Li, ….. Yan Chen, Ming Zhang # . “Spatial enrichment and genomic analyses reveal the link of NOMO1 with amyotrophic lateral sclerosis” Brain, 2024 April 20, online (IF=14.5) (通讯作者)
2. Xuelin Tang, Paulina Gonzalez‐Latapi, Connie Marras, Naomi P Visanji, Wanli Yang, Christine Sato, Anthony E Lang, Ekaterina Rogaeva, Ming Zhang#. “Epigenetic Clock Acceleration Is Linked to Age at Onset of Parkinson's Disease.” Movement Disorders. 2022 Sep;37(9):1831-1840. (IF=10.3) (通讯作者)
3. Jiahao Li, Anli Shu, Yimin Sun, Wanli Yang, Xuelin Tang, Hongjiang Pu, Yun Peng, Xiaowen Hu, Ying Qing, Jian Wang, Chunling Wan, Mingcheng Zhou, Ming Zhang#. “DNA methylation age acceleration is associated with age of onset in Chinese spinocerebellar ataxia type 3 patients.” Neurobiology of Aging. 2022 May;113:1-6. (IF=5.1) (通讯作者)
4. Zhang M#, Zhengrui Xi, Sara Saez-Atienzar et al. “Combined epigenetic/genetic study identified an ALS age of onset modifier”. Acta Neuropathol Commun.2021 Apr 23;9(1):75 (IF=7.6) (通讯作者)
5. Zhang M#, et al. “DNA methylation age acceleration is associated with ALS age of onset and survival”, Acta Neuropathol. 2020; 139(5): 943–946. (IF=18.2) (通讯作者)
6. Zhang M#, et al., “Genetic and epigenetic study of an Alzheimer’s disease family with monozygotic triplets”, Brain 2019 Nov 1;142(11):3375-3381. (IF=14.5) (Editor’s choice)
7. Zhang M#, Ferrari R, Tartaglia MC, et al. “A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers”, Brain. 2018 Oct 1;141(10):2895-2907. (IF=14.5) (通讯作者)
8. Wanli Yang……Ming Zhang#. Investigation of a Fused in Sarcoma Splicing Mutation in a Chinese Amyotrophic Lateral Sclerosis Patient. Canadian Journal of Neurological Sciences 2022 Dec 12;1-6. (IF=3) (通讯作者)
9. M Zhang*, M Rohani, MM Haghighi, C Sato, E Rogaeva, A Fasano. Whole-genome study of a multigenerational family with essential tremor. Canadian Journal of Neurological Sciences 2022 May;49(3):381-386. (IF=3)
10. JF Bally*, M Zhang*, E Dwosh, C Sato, J Rutka, AE Lang, E Rogaeva. Genomic study of a large family with complex neurological phenotype including hearing loss, imbalance and action tremor. Neurobiology of Aging 2022 May;113:137-142. (IF=5.1)
11. Zhang M, et al. “DNA methylation age-acceleration is associated with disease duration and age at onset in C9orf72 patients”, Acta Neuropathol. 2017 Aug;134(2):271-279. (IF=18.2)
12. Philip McGoldrick*, Ming Zhang*, et al., “Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins but upregulated C9orf72 expression”, Neurology, 2017 Oct, (IF=10)
13. Zhang M*, Xi Z*, et al. “Mutation analysis of CHCHD10 in different neurodegenerative diseases”, Brain e1-e4, March 31, 2015. (IF= 14.5)
14. Xi Z*, Zhang M*, et al. “The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients” Acta Neuropathol. 2015 May;129(5):715-27. (IF= 18.2)
15. Xi Z*, van Blitterswijk M*, Zhang M*, et al. “Jump from pre-mutation to pathologic expansion in C9orf72” Am J Hum Genet 2015 Jun 4;96(6):962-70. (IF= 10.1)
16. Zhang M, Xi Z, Ghani M, Jia P, Pal M, Werynska K, Moreno D, Sato C, Liang Y, Robertson J, Petronis A, Zinman L, Rogaeva E, “Genetic and epigenetic study of ALS-discordant identical twins with double mutations in SOD1 and ARHGEF28”. Journal of Neurology, Neurosurgery, and Psychiatry. 2016 Nov;87(11):1268-1270. (IF=10.1)
17. Zhang M*, Xi Z*, Sato C, Moreno D, Liang Y, Slow E, Rogaeva E, Tartaglia MC “C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism” Movement Disorders, 2017 Jan;32(1):158-162. (IF=10)
18. Zhang M, et al. Progesterone receptor membrane component 1 is a functional part of the GLP-1 receptor complex in pancreatic beta cells. Mol Cell Proteomics. 2014 Nov;13(11):3049-62. (IF= 7.3)
19. Zhang M, et al. A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci. 2010 Jan;53(1):112-24. (IF= 10)
